Compare Kroger Co (KR) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kroger Co vs Tilray Brands Inc — how do they compare? Kroger Co trades at $61.64 (market cap $36.27B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Kroger Co is far larger — about 68.4× Tilray Brands Inc's market cap, and Kroger Co pays a 2.54% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kroger Co for 108 Days and Tilray Brands Inc for 31 Days on average.
| KR | TLRY | |
|---|---|---|
Market Cap | $36.27B | $530.54M |
Volume | 8,301,523 | 9,099,075 |
Sector | Consumer Staples | Health |
52-Week High | $75.60 | $17.20 |
52-Week Low | $55.53 | $3.54 |
Typical Hold Time | 108 Days | 31 Days |
Enterprise Value | $57.69B | $684.46M |
Dividend Yield | 2.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kroger (KR) trades at $61.41, up 3.65% with a bullish technical signal and positive analyst sentiment. The stock shows strong fundamentals with $147.12B revenue, 23.11% gross margins, and consistent dividend payments. Recent earnings beat expectations in Q2 2026, while Q1 2026 slightly missed. Technical indicators show the stock trading near pivot point resistance at $62 with solid support at $59-60 levels. The company maintains robust cash flow generation with $5.79B from operations in 2025.
Kroger presents a compelling investment case with attractive valuation (P/S 0.26), strong analyst support (47.72% buy ratings), and $70.62 consensus price target offering 15% upside. Key risks include integration challenges with Giant Eagle acquisition, cost pressures affecting 2026 margins, and competitive threats from Walmart. The stock's digital growth initiatives and retail media expansion provide growth catalysts, though investors should monitor identical sales performance and acquisition integration progress.
Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.
TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
